Literature DB >> 11572894

Arterial changes in paediatric haemodialysis patients undergoing renal transplantation.

A Nayir1, I Bilge, I Kiliçaslan, H Ander, S Emre, A Sirin.   

Abstract

BACKGROUND: The relationship between primary renal disease and arterial wall changes in paediatric haemodialysis patients has been little studied. The aim of the present work was to determine the influence of primary renal disease on arterial wall pathology in uraemic paediatric patients.
METHODS: Twelve paediatric haemodialysis patients (seven girls, five boys) aged 11-17 years were included in the study. The primary renal diseases were urinary malformations in six patients (uropathy group) and acquired glomerular diseases (glomerulopathy group) in six patients. Age, sex distribution, duration of chronic renal failure, duration of haemodialysis, blood pressure, serum glucose, triglycerides, cholesterol, fibrinogen, calcium, phosphorus and parathyroid hormone levels were compared. Internal iliac artery samples were obtained at the time of related-donor renal transplantation. Artery samples were fixed in formaldehyde and sections were stained separately with haematoxylin and eosin, Orcein, Verhoef-van Gieson, and Masson trichrome.
RESULTS: Five arteries had fibrous or fibroelastic intimal thickening, medial mucoid ground substance and disruption of the internal elastic lamella. Two of these had microcalcification in the intimal layer; another two demonstrated atheromatous plaques; the remaining five were normal. These pathological changes were found in the arteries of all six patients with uropathy, whereas of the six patients with glomerulopathy only one had arterial changes (P<0.001). The duration of chronic renal failure was 4.8+/-1.9 years in the uropathy group and 2.2+/-1.2 in the glomerulopathy group (P<0.05). The two groups were comparable in terms of serum glucose, triglycerides, cholesterol, fibrinogen, calcium, and parathyroid hormone levels, presence of hypertension, sex distribution, and duration of haemodialysis. Plasma phosphorus and the calcium x phosphate product were higher in the uropathy group than in the glomerulopathy group (P<0.05).
CONCLUSIONS: This study demonstrated that pathological changes are common in the arteries of uraemic paediatric patients, and that calcification and atherosclerosis are integral to this disease process. In our study, these alterations were more common in the patients with uropathy. We speculate that the patients with uropathy are more prone to these alterations due to slower progression and a longer duration of renal insufficiency.

Entities:  

Mesh:

Year:  2001        PMID: 11572894     DOI: 10.1093/ndt/16.10.2041

Source DB:  PubMed          Journal:  Nephrol Dial Transplant        ISSN: 0931-0509            Impact factor:   5.992


  15 in total

1.  Carotid artery thickness in children and young adults with end stage renal disease.

Authors:  Hakan M Poyrazoğlu; Ruhan Düşünsel; Ali Yikilmaz; Nazmi Narin; Ruksan Anarat; Zübeyde Gündüz; Abdulhakim Coşkun; Ali Baykan; Ahmet Oztürk
Journal:  Pediatr Nephrol       Date:  2006-08-30       Impact factor: 3.714

2.  Report of an NIH task force on research priorities in chronic kidney disease in children.

Authors:  Russell W Chesney; Eileen Brewer; Marva Moxey-Mims; Sandra Watkins; Susan L Furth; William E Harmon; Richard N Fine; Ronald J Portman; Bradley A Warady; Isidro B Salusky; Craig B Langman; Debbie Gipson; Peter Scheidt; Harold Feldman; Frederick J Kaskel; Norman J Siegel
Journal:  Pediatr Nephrol       Date:  2005-10-27       Impact factor: 3.714

Review 3.  Cardiovascular complications in pediatric end-stage renal disease.

Authors:  Rulan S Parekh; Samuel S Gidding
Journal:  Pediatr Nephrol       Date:  2004-12-15       Impact factor: 3.714

Review 4.  Cardiovascular disease in children with chronic kidney disease.

Authors:  Mark M Mitsnefes
Journal:  J Am Soc Nephrol       Date:  2012-03-01       Impact factor: 10.121

Review 5.  Minimizing bone abnormalities in children with renal failure.

Authors:  Helena Ziólkowska
Journal:  Paediatr Drugs       Date:  2006       Impact factor: 3.022

Review 6.  Assessing cardiovascular risk in children with chronic kidney disease. B-type natriuretic peptide: a potential new marker.

Authors:  Gema Ariceta; Ellen R Brooks; Craig B Langman
Journal:  Pediatr Nephrol       Date:  2005-08-05       Impact factor: 3.714

7.  Vitamin D deficiency and arterial wall stiffness in children with chronic kidney disease.

Authors:  Amit R Patange; Rudolph P Valentini; Wei Du; Michael D Pettersen
Journal:  Pediatr Cardiol       Date:  2011-09-13       Impact factor: 1.655

8.  Dyslipidemia in children with chronic kidney disease.

Authors:  Jeffrey M Saland; Christopher B Pierce; Mark M Mitsnefes; Joseph T Flynn; Jens Goebel; Juan C Kupferman; Bradley A Warady; Susan L Furth
Journal:  Kidney Int       Date:  2010-08-25       Impact factor: 10.612

9.  Assessment of the cardiovascular system in pediatric chronic kidney disease: a pilot study.

Authors:  Jutta Muscheites; Andreas Alexander Meyer; Erdmute Drueckler; Marianne Wigger; Dagmar-Christiane Fischer; Guenther Kundt; Wolfgang Kienast; Dieter Haffner
Journal:  Pediatr Nephrol       Date:  2008-07-03       Impact factor: 3.714

10.  What parathyroid hormone levels should we aim for in children with stage 5 chronic kidney disease; what is the evidence?

Authors:  Lesley Rees
Journal:  Pediatr Nephrol       Date:  2007-11-28       Impact factor: 3.714

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.